Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.
Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags Entertainment, Tellurian and Unity Software.
Wednesday's additional top analyst upgrades and downgrades were on Block, Bristol-Myers Squibb, Clorox, CSX, Kimberly-Clark, Merck, Match, Target and more.
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried…
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New York Community Bancorp, Okta, Physicians Realty Trust, Spotify Technology and Welltower.
Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.
Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.
A recent survey of global fund managers found that many have turned to health care for some stability in these uncertain times. These eight high-dividend-paying stocks are rated Buy at top Wall…
Monday's top analyst upgrades and downgrades included Adobe, Arista Networks, AT&T, Bristol-Myers Squibb, Canopy Growth, Deere, Eli Lilly, Invesco, Medtronic, Mosaic, 3M, Roblox, Starbucks, Tesla, Tapestry and Williams Companies.
Friday’s top analyst upgrades and downgrades included Altice USA, AppLovin, Biogen, Bristol-Myers Squibb, Broadcom, Ciena, Cloudflare, Denison Mines, Diageo, Eli Lilly, Rio Tinto and Southwest Airlines.
With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success. These five top health care stocks look like very solid ideas for…
Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets, attractive dividend yields and improved cost structures. With even moderate appreciation in…
Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost structures, and they…
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal…
